pI: 6.7217 |
Length (AA): 437 |
MW (Da): 49410 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_246672)
Species | Accession | Gene Product |
---|---|---|
Schistosoma japonicum | Sjp_0202280 | ko:K05218 purinergic receptor P2X, ligand-gated ion channel 4, putative |
Schmidtea mediterranea | mk4.003738.00 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | P2X purinoceptor 1 | 399 aa | 41.0% | 371 aa | Compounds | References |
Rattus norvegicus | P2X purinoceptor 6 | 379 aa | 36.0% | 381 aa | Compounds | References |
Rattus norvegicus | P2X purinoceptor 4 | 388 aa | 46.0% | 359 aa | Compounds | References |
Canis lupus familiaris | P2X7 purinoceptor | 205 aa | 32.3% | 195 aa | Compounds | References |
Rattus norvegicus | P2X2/P2X3 receptor | 397 aa | 37.0% | 403 aa | Compounds | References |
Rattus norvegicus | P2X purinoceptor 3 | 397 aa | 37.0% | 403 aa | Compounds | References |